SynCore Biotechnology - Pioneering Solutions for Patients

摘要

SynCore Biotechnology (SynCoreBio) is leading the fight against pancreatic cancer. With the lowest survival rate of all 22 common cancers, pancreatic cancer will cause roughly 44,330 deaths this year in the U.S. alone. Owing to the lack of symptoms produced in the early stages, pancreatic cancer is often undetected until advanced progression, making it notoriously difficult to treat.